Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Gamma-tocotrienol (γ-T3), a vitamin E isomer, exhibits broad-spectrum anti-cancer properties.
• γ-T3 demonstrates efficacy in inhibiting cancer cell growth, angiogenesis, metastasis, and targeting cancer stem cells (CSCs).
• The precise molecular mechanisms underlying γ-T3's anti-cancer effects remain largely unelucidated.

Purpose of the Study:

• To identify novel downstream targets of γ-T3 in cancer.
• To investigate the role of the Angiopoietin-1 (Ang-1)/Tie-2 pathway in γ-T3's anti-cancer activity.
• To explore the therapeutic potential of combining γ-T3 with Tie-2 inhibitors.

Main Methods:

• Prostate cancer cell lines were treated with γ-T3.
• Angiopoietin-1 (Ang-1) and Tie-2 expression levels were analyzed at mRNA and protein levels.
• Functional assays were performed to assess the effects of Ang-1 supplementation and Tie-2 inactivation on γ-T3's anti-cancer activity.
• AMP-activated protein kinase (AMPK) activation and autophagy were evaluated.

Main Results:

• γ-T3 treatment suppressed Ang-1 expression in prostate cancer cells.
• Ang-1 supplementation protected cancer cells from γ-T3's anti-CSC effects.
• Inactivation of Tie-2 potentiated γ-T3's cytotoxic effects.
• Tie-2 inactivation led to AMPK activation and autophagy interruption, enhancing γ-T3's efficacy.

Conclusions:

• Angiopoietin-1/Tie-2 signaling is a novel downstream target pathway for γ-T3.
• γ-T3 exhibits anti-cancer effects partly through the modulation of Ang-1/Tie-2 signaling.
• Combination therapy of γ-T3 with Tie-2 inhibitors may represent a promising strategy for advanced prostate cancer treatment.